Concepedia

Author

Di Gu

First Affiliated Hospital of Guangzhou Medical University

Also Known As

Di Gu, Gu Di, Gu, Di

53

Publications

584

Citations

12

H-Index

14

Concepts

All Affiliations

First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou Medical UniversitySecond Military Medical UniversityChanghai HospitalAnshan Hospital
DG

About

Di Gu is an author at First Affiliated Hospital of Guangzhou Medical University specializing in oncology, urology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Pathology

2

2

45

3

Public Health

1

1

20

4

Biostatistics

1

1

20

5

Cancer Epidemiology

1

1

20

Di Gu

×

12

Publications

248

Citations

10

H-Index

YearCitations

Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts

Tao He, Qiansheng Zhang, Peng Xu,

Molecular Cancer

2023

46

Identification and Verification of m7G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma

Kai Dong, Di Gu, Jiazi Shi,

Frontiers in Immunology

2022

32

Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy

Jialin Meng, Aimin Jiang, Xiaofan Lu,

iMeta

2023

28

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy

Daojun Lv, Xiangkun Wu, Xi Chen,

Cancer Immunology Immunotherapy

2021

25

A 10‑gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7

Xiangkun Wu, Daojun Lv, Ming Lei,

Oncology Letters

2020

20

Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle

Qingfeng Yu, Chengjie Wu, Yeda Chen,

Acta Pharmaceutica Sinica B

2021

19

Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments

Yeda Chen, Di Gu, Yaoan Wen,

Cancer Cell International

2020

18

A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients

Xiangkun Wu, Daojun Lv, Md Eftekhar,

Translational Andrology and Urology

2020

14

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

Zude Chen, Xiaoshuang Yang, Zugen Chen,

BMC Medicine

2023

14

Initial experience on extraperitoneal single-port robotic-assisted radical prostatectomy

Yifan Chang, Di Gu, Mei Ni,

Chinese Medical Journal

2020

12

Page 1